Related Experiment Videos
The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program
Gregory A Poland1, John D Grabenstein, John M Neff
1Mayo Vaccine Research Group, and Department of Medicine, Program in Translational Immunovirology and Biodefense, 611 C Guggenheim Building, 200 First Street, SW, Mayo Clinic and Foundation, Rochester, Minnesota, MN, USA. poland.gregory@mayo.edu
Vaccine
|March 10, 2005
Summary
This study details US smallpox vaccination side effects, including myopericarditis. Findings offer crucial data for future vaccinia vaccination programs and clinical trials comparing vaccine complications.
Area of Science:
- Immunology
- Public Health
- Vaccinology
Background:
- Smallpox vaccination is critical for global health security.
- The last large-scale US vaccination program occurred decades ago.
- Understanding vaccinia vaccine side effects is essential.
Purpose of the Study:
- To document US smallpox vaccination experiences in the modern era.
- To quantify anticipated and unanticipated side effects of vaccinia vaccination.
- To identify and analyze unexpected adverse events, such as myopericarditis.
Main Methods:
- Analysis of data from a large-scale US smallpox vaccination program.
- Utilizing the calf-lymph-derived New York City Board of Health strain vaccine (Dryvax, Wyeth).
- Review of local and systemic side effects and unexpected issues.
Main Results:
- The study presents the largest dataset on vaccinia vaccination since the 1970s.
- Identified anticipated and unanticipated local and systemic side effects.
- Documented unexpected adverse events, including myopericarditis.
Conclusions:
- The findings provide valuable insights into smallpox vaccination outcomes.
- This data serves as a benchmark for future vaccinia vaccination programs.
- Results will aid in comparing candidate vaccine side effects in clinical trials.